Both Runx2 and RANKL expressions increased along with the progression of NAFLD, which were moderately elevated in the early stage of NAFLD and obviously aggravated in NASH. This evidence concerns the gene TNFSF11 and metabolic dysfunction-associated steatohepatitis.